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Abstract
© 2016,  Springer  Science+Business  Media  New  York.The  present  study  investigates  the
hepatoprotective effect of a novel zinc-containing drug acyzol in comparison with silymarin, a
medicinal extract of milk thistle (Silybum marianum). The hepatoprotective effect was studied in
40  albino  nonlinear  male  rats  in  a  model  of  toxic  liver  injury  induced  by  intragastric
administration of  carbon tetrachloride.  Both drugs were diluted in  water  and administered
intragastrically at doses 10 mg/kg (acyzol) and 100 mg/kg (silymarin) for 10 days twice daily,
after development of clinical toxic hepatitis. Biochemical and functional indicators of the liver
parenchyma demonstrated that both drugs reduced mortality, normalized the body and relative
liver  weight,  reduced  intensity  of  cytolytic,  cholestatic,  and  mesenchymal  inflammatory
syndromes, and restored liver function. The study demonstrates that acyzol and silymarin have
comparable hepatoprotective effect, thus, providing a rationale for the use of acyzol in complex
therapy of toxic hepatitis and hepatosis.
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Keywords
Acyzol, Carbon tetrachloride (CCl ) 4, Hepatoprotectors, Hepatotoxicity, Rat liver hepatocytes,
Silymarin, Zinc
References
[1] Blachier, M., Leleu, H., Peck-Radosavljevic, M., Valla, D. C., Roudot-Thoraval, F. (2013). The burden of liver
disease in Europe: a review of available epidemiological data. Journal of Hepatology, 58, 593–608.
[2] Zhu, R., Wang, Y., Zhang, L., Guo, Q. (2012). Oxidative stress and liver disease. Hepatology Research, 42,
741–749.
[3] Vladimir-Knežević,  S.,  Cvijanović,  O.,  Blažeković,  B.,  Kindl,  M.,  Bival,  Š.  M.,  Domitrović,  R.  (2015).
Hepatoprotective effects of Micromeria croatica ethanolic extract against CCl–induced liver injury in mice. BMC
Complementary and Alternative Medicine, 15, 233.
[4] Kelleher, S. L., McCormick, N. H., Velasquez, V., Lopez, V. (2011). Zinc in specialized secretory tissues: roles in
the pancreas, prostate, and mammary gland. Advances in Nutrition, 2(2), 101–111.
[5] Malhotra, A.,  & Dhawan, D. K. (2014). Current view of zinc as a hepatoprotective agent in conditions of
chlorpyrifos induced toxicity. Pesticide Biochemistry and Physiology, 112, 1–6.
[6] Liu, J., Zhou, Z. X., Zhang, W., Bell, M. W., Waalkes, M. P. (2009). Changes in hepatic gene expression in
response to hepatoprotective levels of zinc. Liver International, 29(8), 1222–1229.
[7] Radionov, I. A., Shantyr, I. I., Barinov, V. A. (2012). The effect of Acyzol on the kinetics of carboxyhemoglobin in
firemen. Medical and biological, social and psychological security problems in emergency situations, 2, 11–13.
[8] Barinov A.V., Nechiporenko S.P. (2006). The antidote for carbon monoxide poisoning has been developed.
UNIFOR RASHA. 116–117.
[9] Babaniyazova, Z. H., Babaniyazov, H. H., Radionov, I. A., Skalniy, A. V., Bobr, I. S. (2010). Acyzol addressing
zinc deficiency states. Trace Elements in Medicine, 11(1), 25–30.
[10] Lebedeva, S. A., Babaniyazova, Z. H., Radionov, I. A., Skalniy, A. A. (2013). Zinc and cobalt metal complexes in
regenerative treatment of hypoxic conditions. Journal of Restore Medicine Rehabilitation, 2, 67–69.
